Investing in Japan Small & Micro Caps

Jonathan Bates-Kawachi presented his in-depth investment thesis on Sapporo Clinical Labs (9776 JP), Nishikawa Keisoku (7500 JP), Sun Life (4656 JP), Heian Ceremony (2344 JP), Teikoku Sen-I (3302 JP), Kawanishi Holdings (2689
JP), Win Partners (3183 JP) and MT Genex (9820) at Japan Investing Summit 2013.

About the instructor:

Jonathan Bates-Kawachi is a value investor with significant experience researching and investing in the Japanese equity market. While Jonathan is currently managing his own capital with a focus on Japanese small and micro caps, his previous work experience includes working as a research analyst at Fidelity and Deutsche Bank in Tokyo. Jonathan holds a BA from Cambridge University and a Masters in Finance from London Business School. He is fluent in Japanese.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

First name:

Last name:

Email address:

City / state / country:

Company:

How did you hear about MOI Global? Select Member referral Staff This website Media / Internet Other

If referral, please provide member's name:

Which of the following applies most closely to you? Select Investment Firm - Head Investment Firm - Analyst or PM Institutional Allocator - Firm C-Level Executive Institutional Allocator - Firm Employee Family Office - Head or Co-Owner Family Office - Employee Non-Investment Firm - C-Level Executive Non-Investment Firm - Employee Other

How do you hope to add value to the community?

Leave this field empty if you're human: